Mealey's (October 17, 2016, 12:24 PM EDT) -- BOSTON — A pharmaceutical company and certain of its executive officers and directors and others misrepresented the success of clinical test results for the company’s prostate cancer drug in violation of...
Investors Sue Drug Maker Over Clinical Study Result Misrepresentations
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login